TNIK inhibitors (Chinese Academy of Sciences/Shenyang Pharmaceutical University)

N/A

Report date: 2025/03/20 10:05:09
NME

Base Information

Drug NameTNIK inhibitors (Chinese Academy of Sciences/Shenyang Pharmaceutical University)
Drug Alias NameTRAF2 and NCK interacting kinase inhibitors (Chinese Academy of Sciences/Shenyang Pharmaceutical University)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTRAF2 and NCK-interacting protein kinase inhibitors
TargetsTRAF2 and NCK-interacting protein kinase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesChinese Academy Of Sciences
China Registration ClassN/A

Develop Information

Active CompaniesChinese Academy Of SciencesShenyang Pharmaceutical University
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A